Pfizer Unit Hit With Another Suit Over Tossed Lyrica Patent
Ranbaxy has sued Pfizer-owned Warner-Lambert for lost profits, becoming the latest generic-drug maker to seek damages from the years it couldn't launch a version of the blockbuster drug Lyrica because of...To view the full article, register now.
Already a subscriber? Click here to view full article